touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia
The multidisciplinary team
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This medical education is provided by touchIME.
For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ascvd-risk//
Create your
podcast in
minutes
It is Free